Perrigo Earnings
NYSE: PRGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$0.57
Perrigo earnings summary
Perrigo is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.57. In its most recent report on Aug 5, 2026 (Q2 2026), PRGO posted EPS of $0.53. Revenue for the quarter was $1.02 billion.
Across the last 16 reports, PRGO shares moved an average of 5.5% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
PRGO earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.53 | — | +1.6% |
| May 6, 2026 | — | $-2.87 | — | -9.4% |
| Feb 26, 2026 | — | $-10.23 | — | -18.9% |
| Nov 5, 2025 | — | $0.05 | — | -4.6% |
| Aug 6, 2025 | — | $-0.06 | — | +0.7% |
| May 7, 2025 | — | $-0.05 | — | +0.1% |
| Feb 28, 2025 | — | $-0.32 | — | -4.3% |
| Nov 6, 2024 | — | $-0.15 | — | +1.7% |
| Aug 2, 2024 | — | $-0.79 | — | -2.4% |
| May 7, 2024 | — | $0.01 | — | -2.9% |
| Feb 27, 2024 | — | $-0.23 | — | +14.9% |
| Nov 7, 2023 | — | $0.10 | — | +6.0% |
| Aug 8, 2023 | — | $0.06 | — | -3.4% |
| May 9, 2023 | — | $-0.02 | — | -4.4% |
| Feb 28, 2023 | — | $-0.17 | — | -7.5% |
| Nov 8, 2022 | — | $-0.37 | — | -4.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.